Ademi LLP Investigates Claims of Securities Fraud against R1 RCM Inc.
MILWAUKEE, Nov. 9, 2022 /PRNewswire/ -- Ademi LLP is investigating possible securities fraud claims against R1 (Nasdaq: RCM). The investigation results from inaccurate statements R1 may have made regarding its business operations and prospects.
Click here to learn more about the investigation: https://www.ademilaw.com/case/r1-rcm-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.
The investigation focuses on whether R1 properly disclosed that it was experiencing (i) lower incentive fee revenue due to longer payer reimbursement turn-around times, (ii) lower net operating fees due to weaker volumes from emergency department physician customer, and (iii) financial challenges from one of R1's emergency department customers.
If you wish to obtain additional information or have information about this investigation, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, https://www.ademilaw.com/case/r1-rcm-inc.
We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Ademi LLP
Guri Ademi
3620 East Layton Ave.
Cudahy, WI 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001
www.ademilaw.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ademi-llp-investigates-claims-of-securities-fraud-against-r1-rcm-inc-301672998.html
SOURCE Ademi LLP
